4//SEC Filing
Lalwani Nikhil 4
Accession 0001822629-25-000002
CIK 0001023024other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:16 PM ET
Size
8.7 KB
Accession
0001822629-25-000002
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2025-02-12+60,932→ 522,709 total - Award
Common Stock
2025-02-12+91,399→ 461,777 total - Tax Payment
Common Stock
2025-02-14$58.92/sh−7,799$459,517→ 514,910 total
Footnotes (3)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F3]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,132 shares of restricted stock, the grant of which was previously reported.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001822629
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:16 PM ET
- Size
- 8.7 KB